5 Best Booming Stocks to Buy Right Now

4. Cogent Biosciences Inc (NASDAQ:COGT)

Number of Hedge Fund Investors: 33

Earlier this month, Citi started covering Cogent Biosciences Inc (NASDAQ:COGT) with a Buy rating. Citi cited the potential of Cogent’s drug bezuclastinib for the treatment of systemic mastocytosis and gastrointestinal stromal tumors. Citi set an $11 price target on Cogent Biosciences Inc (NASDAQ:COGT).

The stock is up 37% year to date.

Insider Monkey’s database of 933 hedge funds shows that 33 funds had stakes in Cogent Biosciences Inc (NASDAQ:COGT) as of the end of the fourth quarter of 2023.